2026 International Congress Archives - Page 19 of 208

Objective Assessment of the Timed Up and Go Test in Parkinson’s Disease Using AI-Based Markerless Video Analysis

C. Ferraris, G. Amprimo, S. Gallo, G. Imbalzano, M. Patera, M. Ghislieri, G. Olmo, A. Suppa, CA. Artusi (Turin, Italy)
Objective Characteristics and Brain Network Alterations in Early-Stage Parkinson’s Disease with Gastric Motility Disorder

J-Y. Jin, X-Y. Cheng, C-J. Mao, C-F. Liu (Suzhou, China)
Objective detection of morning bradykinesia in Parkinson’s Disease using a wearable inertial sensor

N. Caballol, A. ávila, A. Planas-Ballvé, A. Peral, P. Lombardo, A. Pérez-Soriano, A. Bayés, P. Quispe, S. Belmonte, J. Hernández-Vara, D. Cerdan, I. Cabo, N. López-Ariztegui, T. Delgado, J. Herreros-Rodríguez, D. Santos-García, C. Cores-Bartolomé, G. Jarasunas-Cardozo, J. Casanova-Mollà, C. Pérez-López (Sant Joan Despí, Spain)
Objective Parkinson’s Diagnosis Using a Novel Accelerometer Assessment and Machine Learning

L. Jurcaga, E. Amigo, J. Oyaga-Orus, S. Aldea-Campillo, J. Marín-Lahoz, M. Vallejo (Edinburgh, United Kingdom)
Objective profiling of parkinsonian and essential tremor using EMG and accelerometry

F. Alonso-Frech, C. Machí, D. Ortiz-Zacarías, O. Obika, T. Jiménez, R. Martínez-Fernández, M. Matarazzo (Madrid, Spain)
Occupational Pesticide Exposure, Personal Protective Equipment, and Parkinson’s Disease: An Observational Study from the PPMI Cohort

B. Gonzalez-Bedolla, F. Luna-Rangel, S. Robles-Bernal, E. Santiago-Delacruz, D. Rebolledo-Garcia (Monterrey, Mexico)
Occupational Solvent Exposure and Parkinson’s Disease: An Observational Study in PPMI Online

F. Luna-Rangel, H. Martinez, O. Gutierrez-Treviño, C. Armengol-Garcia, J. Luna, B. Perez Martinez, J. Figueroa-Sanchez (San Pedro, Mexico)
Oculomotor Abnormalities in the Spinocerebellar Ataxias: A Large Cohort Analysis

L. Shimanovich, M. Taha, C. Gomez (Chicago, USA)
Odor‑specific olfactory dysfunction in early‑onset Parkinson’s disease

D. Larina, E. Bagdasarova, I. Zdorovec, A. Shekhvatova, K. Nazarova, M. Nikolaeva, I. Miliukhina, A. Murtazina, E. Bril, O. Turgunkhujaev (Saint-Petersburg, Russian Federation)
Olfactory Dysfunction Across Neurodegenerative Disorders: A Prospective Cross-Sectional Comparison of Parkinson’s Disease, Alzheimer’s Disease and Idiopathic REM Sleep Behavior Disorder

J. Einhaus, E. Kara, H. Jergas, C. Schedlich-Teufer, G. Tamgüney, G. Fink, M. Sommerauer, ö. Onur, M. Barbe (Jülich, Germany)
Olfactory Dysfunction in Parkinson’s Disease: A Single-Center Study Using the Alcohol Sniff Test

S. Marisdina, U. Manurung (Palembang, Indonesia)
Olfactory Function as a Biomarker of Disease Progression in Progressive Supranuclear Palsy

Q. Shen, XY. Li, J. Wang, FT. Liu (Shanghai, China)
Olfactory Groove Meningioma Presenting with Recurrent Falls and Dystonic Head Tremor An Unusual Clinical Presentation

I. Eltazi, Y. Imam (Doha, Qatar)
Oligodendrocyte-Specific α-Synuclein Pathology is Linked to Severe Motor Phenotype in a Novel Mouse Model of Multiple System Atrophy

J. Bergstrom, Y. Liang, K. Luk (Philadelphia, USA)
Omaveloxolone in a real-world setting: implications in Friedreich Ataxia beyond the classic study population

W. Nachbauer, M. Amprosi, D. Boesch, M. Schranz, E. Indelicato, L. Schwaighofer, S. Boesch (Innsbruck, Austria)
One day accelerated 10 Hz rTMS for Focal Hand Dystonia: A Phase II Clinical Trial

I. Xu, Z. Simsek, P. Mulcahey, C. Bui, Y. Li, N. Hamzah, A. Norain, M. Lipp, D. Bitlis, S. Dave, K. Grozev, C. Russell, C. Petty, M. Lutz, A. Peterchev, N. Bukhari-Parlakturk (Durham, USA)
One-Year Outcomes of Radiofrequency Thalamotomy Versus MR-Guided Focused Ultrasound: A Prospective Single-Centre Comparative Study

M. Mohamad, S. Idris, J. Candelario-Mckeown, C. Hartigan, J. Esperida, M. Salazar, J. Hyam, T. Foltynie, H. Akram, P. Limousin, M. Krueger, L. Zrinzo, S. Xu (London, United Kingdom)
One-Year Trajectories of Non-Motor Symptoms in Parkinson’s Disease: A Longitudinal Cohort Study Using the MDS-NMS with Age at Onset Stratification

D. Faldu, S. Prasad, T. Nagaraj, S. Bhat, M. Bhardwaj, SS. Aramugham, K. Kumar, R. Mahale, P. Mailankody, V. Holla, N. Kamble, R. Yadav, P. Pal (Bengaluru, India)
Online Assessments Measure Motor and Cognitive Progression in People with and without Parkinson’s Disease

E. Brown, X. Chen, P. Gonzalez Latapi, D. Weintraub, C. Marras, N. Pavese, L. Chahine, W. Poewe, R. Dobkin, K. Chou, E. Tolosa, A. Noyce, C. Stanley, T. Tropea, L. Racelo, M. Korell, K. Marek, C. Tanner (San Francisco, USA)
Opicapone as adjunct to levodopa in Chinese patients with Parkinson’s disease and wearing-off: a randomized, double-blind, placebo-controlled phase 3 trial

S. Chen, Y. Tan (Shanghai, China)
Opicapone Co-administration Allows Significant Flow Reduction in Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion: A Real-World Case Series

G. Tabar Comellas, N. Lopez Ariztegui, M. Morales Casado (TOLEDO, Spain)
Opicapone for Management of Sleep Disturbances in Parkinson’s Disease: Post-hoc Analysis of the OASIS trial in Patients With and Without Probable RBD

G. Banisadr, J. Ferreira, M. Gago, R. Costa, M. Fonseca, H. Brigas, S. Fisher, J. Holenz, C. Trenkwalder (Bridgewater, USA)
Opsoclonus-Myoclonus-Ataxia Syndrome in Adults: Case Series in Vietnam

N. Bui, C. Luong, K. Vo (Ha Noi, Viet Nam)
Optimal and invariant hierarchical cognitive indices in the Parkinson’s Progression Markers Initiative

D. González, W. Kent, G. Springer, A. Karstens (Chicago, USA)
Optimizing Identification of Hyposmia for Parkinson’s Disease Risk Screening: Results from the Healthy Brain Aging Study

C. Theyer, S. Leiter, CG. Horlings, I. Egner, F. Krismer, S. Meyer, A. Noyce, E. Tolosa, A. Garrido, D. Pilco-Janeta, S. Ghosh, K. Rege, R. Krüger, M. Marti, V. Satagopam, B. Mollenhauer, C. Trenkwalder, K. Seppi, W. Poewe, P. Mahlknecht (Innsbruck, Austria)
Optimizing Institutional Long-Term Care in Advanced Parkinson’s and Other Neurodegenerative Disease: The OPTICARE Study

J. Stuempel, J. Braun, J. Wolters, C. Woopen, B. Schmitz-Luhn (Bonn, Germany)
Optogenetic mediated inhibition of the subthalamic nucleus alleviates motor symptoms in experimental hemi-parkinsonism mouse model

S. Sobol, Y. Schiller (HAIFA, Israel)
Oral D1-like/D2-like Receptor Agonist, Lu AF28996, Provides Robust Antiparkinsonian Efficacy with Reduced Dyskinesia in the MPTP-Macaque Model

H. Lindgren, E. Bezard (Copenhagen, Denmark)
Oral Frailty in Patients with Parkinson’s Disease: A Cross-Sectional Study Using the OF-5 Checklist

S. Ueno, R. Kurisaki, Y. Oike, A. Fujimoto, M. Nakao, K. Harada, M. Toda, C. Nagatoshi, N. Tawara, M. Ishizaki, Y. Nishida, Y. Maeda (Koshi, Japan)
Oscillatory characterization of the STN beyond the resting state in patients with Parkinson’s disease.

A. González-Monzón, I. Aviles-Olmos, M. Alegre Esteban, L. Gonzalez-Quarante, P. Clavero, M. Ruiz-López, B. Tijero Merino, JC. Gomez Esteban, CJ. Madrid Navarro, L. Triguero Cueva, F. Escamilla Sevilla, M. Sierra, C. Velásquez, M. Valencia Ustarroz (Pamplona, Spain)
Outcomes from Unilateral MR-Guided Focused Ultrasound Pallidothalamic Tractotomy for Advanced Parkinson’s Disease

H. Sarva, K. Gant, C. Modak, C. Ferrer, A. Sokolov, A. Grinspan (New York, USA)
Outcomes of a new electromyography-guided botulinum toxin injection clinic for medication-refractory upper limb tremor

R. Hoe, S. Neo (Singapore, Singapore)
Outcomes of Bilateral Deep Brain Stimulation Following Prior MR-guided Focused Ultrasound Thalamotomy

A. Zoana, M. Lotia, N. Reddy, A. Ahmed, C. Reddy (Orlando, USA)
Outpatient Multidisciplinary Care for Parkinson’s Disease: A Narrative Review of Care Models and Outcomes

T-J. Liu, N. Nguyen, P. Isaac, C. Agis, S. Horn, P. Coss, L. Saadatpour, E. Vaou (San Antonio, USA)
Overactive Bladder in Parkinson’s Disease: A Frequent but Underrecognized Non-Motor Symptom

AR. Rahma, N. Raisa, DR. Rahmawati, H. - (Malang, Indonesia)